2000
DOI: 10.1006/cyto.1999.0621
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of Non-Viral Transfection Methods in Melanoma Cell Primary Cultures

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
5
0

Year Published

2003
2003
2016
2016

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 9 publications
1
5
0
Order By: Relevance
“…However, studies of other lipofection agents, including PrimeFectort (EquiBio, Ashford, UK), EasyFectort (EquiBio) and SuperFectt (Qiagen) have yielded transfection efficiencies lower than those of electroporation and LipofectAMINEt. 46 In the present study, the efficiency of PDBA-mediated gene transfer was 21.4%, which is similar to that of LipofectAMINEt. Therefore, PDBA-mediated gene transfer appears to be a safe and effective method.…”
Section: Discussionsupporting
confidence: 82%
See 1 more Smart Citation
“…However, studies of other lipofection agents, including PrimeFectort (EquiBio, Ashford, UK), EasyFectort (EquiBio) and SuperFectt (Qiagen) have yielded transfection efficiencies lower than those of electroporation and LipofectAMINEt. 46 In the present study, the efficiency of PDBA-mediated gene transfer was 21.4%, which is similar to that of LipofectAMINEt. Therefore, PDBA-mediated gene transfer appears to be a safe and effective method.…”
Section: Discussionsupporting
confidence: 82%
“…Non-viral vectors may be good clinical options because they are safer and less labor intensive than virus-based methods; however, present non-viral transfection efficiencies need to be improved. Bettina et al 46 reported a 2379% transfection efficiency for LipofectAMINEt (Invitrogen)-based transfection of primary malignant lymphoma cells with vector expressing the IL-2 gene. However, studies of other lipofection agents, including PrimeFectort (EquiBio, Ashford, UK), EasyFectort (EquiBio) and SuperFectt (Qiagen) have yielded transfection efficiencies lower than those of electroporation and LipofectAMINEt.…”
Section: Discussionmentioning
confidence: 99%
“…[1][2][3][4][5][6][7] It is an attractive approach for gene therapy as it is the most efficient among nonviral methods. [8][9][10] In contrast with virus-based transfection, DNA delivered by electroporation is not fully optimized with respect to overcoming cellular barriers such as the plasma membrane, cytoplasmic crowding, or the nuclear envelope. However, electroporation has the advantage of being safer because complications such as viral infections cannot occur.…”
Section: Introductionmentioning
confidence: 99%
“…Non-viral methods include the use of electroporation and liposomes. These methods have been compared without consistent demonstration of superior transfection efficiency [27,28]. Viral and non-viral vectors have also been compared and similar levels of transfection efficiency were seen, [29] though the clinical efficacy and immunogenicity of viral and non-viral vectors have not been directly compared.…”
Section: Whole Cell-only Strategies: Genetic Modificationmentioning
confidence: 99%